Terms: = Colorectal cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Diagnosis
75 results:
1. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. Extended Enrichment for Ultrasensitive Detection of Low-Frequency Mutations by Long Blocker Displacement Amplification.
Si Y; Wang X; Su X; Weng Z; Hu Q; Li Q; Fan C; Zhang DY; Wang Y; Luo S; Song P
Angew Chem Int Ed Engl; 2024 May; 63(19):e202400551. PubMed ID: 38416545
[TBL] [Abstract] [Full Text] [Related]
3. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
[TBL] [Abstract] [Full Text] [Related]
4. An incidental traditional serrated adenoma of the gallbladder: A case report.
Abecia Martínez EI; Ríos Ballestín G; Castillo Malla J; Martínez Arnau N; Hörndler Argarate C
Rev Esp Patol; 2023; 56(4):271-274. PubMed ID: 37879824
[TBL] [Abstract] [Full Text] [Related]
5. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
Lawler T; Parlato L; Warren Andersen S
Cancer Causes Control; 2024 Feb; 35(2):223-239. PubMed ID: 37688643
[TBL] [Abstract] [Full Text] [Related]
6. The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of "Management of Advanced Primary and Secondary Liver Malignancies".
Schwantes IR; Mayo SC
Surgery; 2023 Aug; 174(2):422-424. PubMed ID: 37183133
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of Circulating Tumor DNA in Synchronous Metastatic colorectal cancer at diagnosis Predicts Overall Patient Survival.
Sayagués JM; Montero JC; Jiménez-Pérez A; Del Carmen S; Rodríguez M; Vidal Tocino R; Montero E; Sanz J; Abad M
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176143
[TBL] [Abstract] [Full Text] [Related]
8. European expert panel consensus on the clinical management of BRAF
Martinelli E; Arnold D; Cervantes A; Stintzing S; Van Cutsem E; Tabernero J; Taieb J; Wasan H; Ciardiello F
Cancer Treat Rev; 2023 Apr; 115():102541. PubMed ID: 36931147
[TBL] [Abstract] [Full Text] [Related]
9. The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis.
Zhang M; Meng L; Zhang Z; Wu J; Chen X; Wang Y; He J
BMC Med Genomics; 2022 Dec; 15(1):259. PubMed ID: 36517805
[TBL] [Abstract] [Full Text] [Related]
10. KRAS, nras, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania.
Brinzan CS; Aschie M; Cozaru GC; Deacu M; Dumitru E; Burlacu I; Mitroi A
Medicine (Baltimore); 2022 Oct; 101(40):e30979. PubMed ID: 36221415
[TBL] [Abstract] [Full Text] [Related]
11. Alarming Drop in Early Stage colorectal cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
[TBL] [Abstract] [Full Text] [Related]
12. Clinicogenomic Characteristics and Treatment of Young-Onset colorectal cancer Patients Treated With Palliative Therapy in Real-World Practice.
Jeong H; Lee E; Kim D; Kim J; Kim SY; Hong YS; Kim TW; Kim JE
Cancer Control; 2022; 29():10732748221096842. PubMed ID: 35475677
[TBL] [Abstract] [Full Text] [Related]
13. Performance of Idylla
Makutani Y; Sakai K; Yamada M; Wada T; Chikugo T; Satou T; Iwasa Y; Yamamoto H; de Velasco MA; Nishio K; Kawamura J
Int J Clin Oncol; 2022 Jul; 27(7):1180-1187. PubMed ID: 35474548
[TBL] [Abstract] [Full Text] [Related]
14. KRAS and nras mutational analysis in plasma ctDNA from patients with metastatic colorectal cancer by real-time PCR and digital PCR.
Pinheiro M; Peixoto A; Rocha P; Veiga I; Pinto C; Santos C; Pinto P; Guerra J; Escudeiro C; Barbosa A; Silva J; Teixeira MR
Int J Colorectal Dis; 2022 Apr; 37(4):895-905. PubMed ID: 35303157
[TBL] [Abstract] [Full Text] [Related]
15. diagnosis and Treatment of ERBB2-Positive Metastatic colorectal cancer: A Review.
Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
[TBL] [Abstract] [Full Text] [Related]
16. Ongoing and evolving clinical trials enhancing future colorectal cancer treatment strategies.
Ros J; Saoudi N; Salvà F; Baraibar I; Alonso G; Tabernero J; Elez E
Expert Opin Investig Drugs; 2022 Mar; 31(3):235-247. PubMed ID: 35133234
[TBL] [Abstract] [Full Text] [Related]
17. Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients.
Foppa C; Tamburello S; Maroli A; Carvello M; Poliani L; Laghi L; Malesci A; Montorsi M; Perea J; Spinelli A
Eur J Surg Oncol; 2022 Apr; 48(4):857-863. PubMed ID: 34740480
[TBL] [Abstract] [Full Text] [Related]
18. Application of ensemble clustering and survival tree analysis for identifying prognostic clinicogenomic features in patients with colorectal cancer from the 100,000 Genomes Project.
Wei Y; Papachristou N; Mueller S; ; Chang WH; Lai AG
BMC Res Notes; 2021 Oct; 14(1):385. PubMed ID: 34600575
[TBL] [Abstract] [Full Text] [Related]
19. Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data.
Fernández Montes A; Carmona-Bayonas A; Jimenez-Fonseca P; Vázquez Rivera F; Martinez Lago N; Covela Rúa M; Cousillas Castiñeiras A; Gonzalez Villarroel P; De la Cámara Gómez J; Méndez JCM; Carriles Fernández C; Sanchez Cánovas M; Garcia García T
Sci Rep; 2021 Jul; 11(1):14321. PubMed ID: 34253805
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic colorectal cancer.
Diehl TM; Abbott DE
Curr Treat Options Oncol; 2021 Jul; 22(9):82. PubMed ID: 34224023
[TBL] [Abstract] [Full Text] [Related]
[Next]
